Robert G. Pietrusko
Conseiller Juridique Général chez VOR BIOPHARMA INC.
Profil
Robert G.
Pietrusko is currently the Chief Regulatory & Quality Officer at Vor Biopharma, Inc. Prior to this, he was the SVP-Regulatory Affairs & Quality Assurance at Voyager Therapeutics, Inc. from 2014 to 2020.
He was also the Senior Vice President-Worldwide Regulatory Affairs at Millennium Pharmaceuticals, Inc. from 2001 to 2007, Vice President-Regulatory Affairs at Shire ViroPharma, Inc. from 2007 to 2009, and Vice President-Regulatory Affairs at GSK Plc from 1999 to 2000.
Dr. Pietrusko received his undergraduate degree from Rutgers State University of New Jersey and his doctorate degree from Philadelphia College of Pharmacy.
Postes actifs de Robert G. Pietrusko
| Sociétés | Poste | Début |
|---|---|---|
| VOR BIOPHARMA INC. | Conseiller Juridique Général | 01/04/2020 |
Anciens postes connus de Robert G. Pietrusko
| Sociétés | Poste | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Conseiller Juridique Général | 01/03/2020 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Conseiller Juridique Général | 01/05/2007 |
| GSK PLC | Conseiller Juridique Général | 01/01/2000 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Conseiller Juridique Général | - |
Formation de Robert G. Pietrusko
| Rutgers State University of New Jersey | Undergraduate Degree |
| Philadelphia College of Pharmacy | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GSK PLC | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
